The US Food and Drug Administration (FDA) issued a Warning Letter to Naturich Cosmetique Labs, Garland, TX. FDA found violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals. Specifically, FDA said: Naturich failed to establish adequate written procedures for production and process control designed to assure that the drug products manufactured have the identity, strength, quality and purity they purport or are represented to possess (21 CFR 211.100(a)). F...